Dexcom Inc
(NQ:
DXCM
)
69.34
-0.28 (-0.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dexcom Inc
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark
March 14, 2022
DexCom Inc's (NASDAQ: DXCM) Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older...
Via
Benzinga
Could A Simple Device Help Revolutionize Medical Diagnostics? This Company Thinks So
March 04, 2022
Image provided by Know Labs This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Know...
Via
Benzinga
DexCom's Glucose Monitoring System Snags Breakthrough Device Tag For Hospital Use
March 02, 2022
The FDA granted Breakthrough Device Designation for DexCom Inc (NASDAQ: DXCM) for continuous glucose monitoring (CGM) use in the hospital setting. Dexcom CGM...
Via
Benzinga
Dexcom Announces Upcoming Virtual Conference Presentations
February 14, 2022
From
DexCom, Inc.
Via
Business Wire
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
DexCom Stock Falls As Q4 Profit, FY22 Sales Outlook Trail Wall Street Estimates
February 11, 2022
DexCom Inc's (NASDAQ: DXCM)
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Recap: DexCom Q4 Earnings
February 10, 2022
DexCom (NASDAQ:DXCM) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by...
Via
Benzinga
Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 10, 2022
From
DexCom, Inc.
Via
Business Wire
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
What 5 Analyst Ratings Have To Say About DexCom
February 03, 2022
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter:
Via
Benzinga
Where DexCom Stands With Analysts
January 07, 2022
Over the past 3 months, 6 analysts have published their opinion on DexCom (NASDAQ:
Via
Benzinga
DexCom: This Life Saving Tech Could Double Your Money In Two Years
December 26, 2021
Despite a global rise in variants of COVID-19, one of last year’s hottest plays on the pandemic shutdowns is getting absolutely slaughtered this year.
Via
Talk Markets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes
February 03, 2022
From
Dexcom, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...
Via
Benzinga
7 Best Mutual Funds to Buy for February
January 28, 2022
Mutual funds are generally considered less risky. Here are seven mutual funds tailored to different investment objectives and risk profiles.
Via
InvestorPlace
Dexcom Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 10, 2022 at 4:30 p.m. Eastern Time.
January 24, 2022
From
DexCom, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
January 19, 2022
Raymond James cut DexCom, Inc. (NASDAQ:DXCM) pri...
Via
Benzinga
IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today
January 10, 2022
Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 10, 2022
Gainers Molecular Partners (NASDAQ:MOLN) shares rose 26.6% to $20.9 during Monday's pre-market session. The company's market cap stands at $674.6 million. Apria (...
Via
Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial
January 10, 2022
From
DexCom, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
DexCom, Inc.
Via
Business Wire
IBM Artificial Intelligence Supercomputer Watson Has 8 Stock Picks For 2022
December 29, 2021
It’s the time of year that investors consider which stocks to buy and sell to build their portfolio for the next 12 months. Inflati...
Via
Benzinga
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
December 03, 2021
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.
Via
InvestorPlace
Dexcom Announces Upcoming Conference Presentation
November 29, 2021
From
DexCom, Inc.
Via
Business Wire
3 Reasons This Stock Could 10X in 10 Years
November 18, 2021
This healthcare company isn't done beating the market.
Via
The Motley Fool
Better Buy: DexCom or Abbott Labs?
November 17, 2021
Abbott's the heavyweight, and DexCom is the formidable challenger.
Via
The Motley Fool
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.